We would like to inform you today that BÜHLMANN Laboratories AG now has the fastest SARS-CoV-2 Antigen (Ag) rapid test on the market in its portfolio, which has just been validated and approved by the BAG.
We would like to inform you today that BÜHLMANN Laboratories AG now has the fastest SARS-CoV-2 Antigen (Ag) rapid test on the market in its portfolio, which has just been validated and approved by the BAG.
We are pleased to announce the new AllplexTM SARS-CoV-2 Master Assay from Seegene today.
We are happy to announce that BÜHLMANN Laboratories AG has two new, attractive SARS-CoV-2 Antigen (Ag) rapid tests in its portfolio.
South Korea’s biotechnology firm Seegene (KQ096530) said Monday it developed the world’s first COVID-19 diagnostic variant test, capable of screening COVID-19 and identifying multiple mutant variations in a single reaction.
Social Links